These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 826923

  • 1. A mass fragmentographic method for the determination of chlorpromazine and two of its active metabolites in human plasma and CSF.
    Alfredsson G, Wode-Helgodt B, Sedvall G.
    Psychopharmacology (Berl); 1976 Jul 28; 48(2):123-31. PubMed ID: 826923
    [Abstract] [Full Text] [Related]

  • 2. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
    Alfredsson G, Bjerkenstedt L, Edman G, Härnryd C, Oxenstierna G, Sedvall G, Wiesel FA.
    Acta Psychiatr Scand Suppl; 1984 Jul 28; 311():49-74. PubMed ID: 6199949
    [Abstract] [Full Text] [Related]

  • 3. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed drug doses.
    Wode-Helgodt B, Alfredsson G.
    Psychopharmacology (Berl); 1981 Jul 28; 73(1):55-62. PubMed ID: 6785790
    [Abstract] [Full Text] [Related]

  • 4. Clinical effects and drug concentrations in plasma and cerebrospinal fluid in psychotic patients treated with fixed doses of chlorpromazine.
    Wode-Helgodt B, Borg S, Fyrö B, Sedvall G.
    Acta Psychiatr Scand; 1978 Aug 28; 58(2):149-73. PubMed ID: 358755
    [Abstract] [Full Text] [Related]

  • 5. Plasma nor1-chlorpromazine concentrations: effects of age, race, and sex.
    Young RC.
    Ther Drug Monit; 1986 Aug 28; 8(1):23-6. PubMed ID: 3961892
    [Abstract] [Full Text] [Related]

  • 6. Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: application to biological fluids.
    Gruenke LD, Craig JC, Klein FD, Nguyen TL, Hitzemann BA, Holaday JW, Loh HH, Braff L, Fischer A, Glick ID.
    Biomed Mass Spectrom; 1985 Dec 28; 12(12):707-13. PubMed ID: 2936401
    [Abstract] [Full Text] [Related]

  • 7. Promazine. A major plasma metabolite of chlorpromazine in a population of chronic schizophrenics.
    Sgaragli G, Ninci R, Della Corte L, Valoti M, Nardini M, Andreoli V, Moneti G.
    Drug Metab Dispos; 1986 Dec 28; 14(2):263-6. PubMed ID: 2870904
    [Abstract] [Full Text] [Related]

  • 8. Dehalogenation and N-dealkylation of chlorpromazine as revealed by plasma concentrations of metabolites in a population of chronically medicated schizophrenics.
    Valoti M, Palmi M, Della Corte L, Nardini M, Corti P, Sgaragli GP.
    Methods Find Exp Clin Pharmacol; 1992 Dec 28; 14(6):445-50. PubMed ID: 1469953
    [Abstract] [Full Text] [Related]

  • 9. Does a plasma level of chlorpromazine help?
    Van Putten T, May PR, Jenden DJ.
    Psychol Med; 1981 Nov 28; 11(4):729-34. PubMed ID: 6119719
    [Abstract] [Full Text] [Related]

  • 10. The distribution and metabolism of chlorpromazine in rats and the relationship to effects on cerebral monoamine metabolism.
    Wiesel FA, Alfredsson G.
    Eur J Pharmacol; 1976 Dec 28; 40(2):263-72. PubMed ID: 991935
    [Abstract] [Full Text] [Related]

  • 11. Development of radioimmunoassay for chlorpromazine.
    Kawashima K, Dixon R, Spector S.
    Eur J Pharmacol; 1975 Dec 28; 32(02):195-202. PubMed ID: 1149806
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.
    Swahn C-G, Sandgárde B, Wiesel F-A, Sedvall G.
    Psychopharmacology (Berl); 1976 Jul 28; 48(2):147-53. PubMed ID: 826926
    [Abstract] [Full Text] [Related]

  • 13. How long does chlorpromazine last?
    Lacoursiere RB, Spohn HE.
    J Nerv Ment Dis; 1976 Oct 28; 163(4):267-75. PubMed ID: 972329
    [Abstract] [Full Text] [Related]

  • 14. The use of a side effect as a qualitative indicator of plasma chlorpromazine levels.
    Chetty M, Gouws E, Miller R, Moodley SV.
    Eur Neuropsychopharmacol; 1999 Jan 28; 9(1-2):77-82. PubMed ID: 10082231
    [Abstract] [Full Text] [Related]

  • 15. Important metabolites to measure in pharmacodynamic studies of chlorpromazine.
    Chetty M, Moodley SV, Miller R.
    Ther Drug Monit; 1994 Feb 28; 16(1):30-6. PubMed ID: 8160251
    [Abstract] [Full Text] [Related]

  • 16. Determination of seven selected antipsychotic drugs in human plasma using microextraction in packed sorbent and gas chromatography-tandem mass spectrometry.
    da Fonseca BM, Moreno IE, Barroso M, Costa S, Queiroz JA, Gallardo E.
    Anal Bioanal Chem; 2013 May 28; 405(12):3953-63. PubMed ID: 23314486
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
    Kolakowska T, Wiles DH, Gelder MG, McNeilly AS.
    Psychopharmacology (Berl); 1976 Aug 26; 49(1):101-7. PubMed ID: 8814
    [Abstract] [Full Text] [Related]

  • 19. Protein binding of chlorpromazine in cerebrospinal fluid and serum.
    Alfredsson G, Sedvall G.
    Int Pharmacopsychiatry; 1980 Aug 26; 15(5):261-9. PubMed ID: 7263148
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
    Wiles DH, Kolakowska T, McNeilly AS, Mandelbrote BM, Gelder MG.
    Psychol Med; 1976 Aug 26; 6(3):407-15. PubMed ID: 996201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.